Read the
Over the course of a 8-week study, the presence of phosphorus and a variety of pharmaceuticals and personal care products (PPCPs), ranging from ointments to medications, were monitored after adding Actiflo® Carb to the traditional wastewater treatment process. With the use of Actiflo® Carb, 75 percent of the selected PPCPs were removed from the wastewater before it was released into the environment. Additionally, phosphorus was reduced to a concentration of 0.05 mg/L or less, well below the U.S. EPA's regulatory limit set at 1.0 mg/L.
As part of a multi-year partnership with a team of scientists from the University of Wisconsin-Milwaukee (UWM), the Actiflo® Carb study was conducted by process engineers from Veolia and its subsidiary Kruger Inc., with the support of the Milwaukee Metropolitan Sewerage District (MMSD). The study was released at the annualWEFTEC conference and coincides with the 40th anniversary of the Clean Water Act.“Actiflo Carb goes beyond conventional processes in its ability to remove phosphorous, pharmaceuticals and other trace organics found in ever-larger quantities in our water supply. We believe it will give wastewater facilities a way to stretch their treatment dollars while dramatically reducing pollution levels and achieving better water quality.” Jim Hurst, Chief Technical Officer of Veolia Water North America.